Before eating a healthy lunch with friends, Megan Fisher, a senior mechanical engineering major, slipped away quietly to check her insulin pump, a tedious chore she must perform before every meal.

A mobile app used with an insulin pump that led to 224 injuries was recalled by Tandem Diabetes Care, the FDA announced today. The recall is for the 2.7 version of the Apple iOS t:connect mobile app, ...

NEW YORK (Reuters Health) - Many children and teens using insulin pumps to control type 1 diabetes experience skin problems at the infusion catheter insertion site, but few report thinking about ...

(Reuters Health) – - When diabetic patients report problems with their insulin pumps, the pump manufacturers collect that information – but there’s no easy way for researchers to analyze the data ...

Pump vs control sites had greater vessel density, fibrosis, fibrinogen, and inflammation including eosinophils, insulin-like-growth factor-1 (IGF-1), and transforming growth factor (TGF) β-3, as well ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G, and ...

Medtronic MiniMed insulin pumps are being recalled due to an issue that can lead to incorrect dosing. The affected pumps include the MiniMed 630G and MiniMed 670G. The recall affects 322,055 devices.

The FDA announced an international Class 1 recall of 322,005 Medtronic’s MiniMed 600 Series Insulin Pumps that can cause the user to receive an incorrect amount of insulin. According to the recall ...

Federal regulators have warned Johnson & Johnson that it could face fines and other sanctions for selling faulty insulin pumps and delaying disclosures of serious injuries to diabetics who used them.

Medtronic on Thursday reported a cybersecurity flaw in its older-model insulin pumps. The company has notified customers that the flaw could make the devices vulnerable to hackers. If someone were to ...

The widening quality problems at health giant Johnson & Johnson have former regulators and analysts mystified, as yet another J&J business — at least the seventh — has come under scrutiny. The lapses ...